RankingsPricing
  1. US-listed companies
  2. PTC THERAPEUTICS, INC.
  3. Financials
  4. Common stock and paid-in capital

PTC THERAPEUTICS, INC.PTCT

Market cap
$5.9B
P/E ratio
SummaryFinancials
Period EndCommon stock and paid-in capital (Million USD)YoY (%)
Dec 31, 20242,575+4.39%
Dec 31, 20232,466+6.99%
Dec 31, 20222,305+8.54%
Dec 31, 20212,124-2.22%
Dec 31, 20202,172+20.96%
Dec 31, 20191,795+39.38%
Dec 31, 20181,288+33.27%
Dec 31, 2017967+12.89%
Dec 31, 2016856+4.39%
Dec 31, 2015820+13.64%
Dec 31, 2014722+55.13%
Dec 31, 2013465

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)